Joint Transnational Call for Proposals (JTC 2015): Immunology and immunotherapy of Cancer - strengthening the translational aspects

Basic Information

In the past few years, the increased understanding of the human immune system, of the basic mechanisms involved in the recognition of cancer cells by innate and acquired immune cells and of escape pathways put in place by cancer and its microenvironment have paved the way to the development of innovative immunotherapeutic strategies. In the context of Translational Research, this topic will comprise three specific aims which concur to the possible clinical applications. Proposals will have to cover at least one of the specific areas listed under each aim below. Projects should be built from a solid and established hypothesis and should be relevant with regards to the possible improvements in clinical practices.

Network TRANSCAN-2
Website http://www.transcanfp7.eu/transcan/mod/resource/view.php?id=87
Aim of the joint call In the past few years, the increased understanding of the human immune system, of the basic mechanisms involved in the recognition of cancer cells by innate and acquired immune cells and of escape pathways put in place by cancer and its microenvironment have paved the way to the development of innovative immunotherapeutic strategies. In the context of Translational Research, this topic will comprise three specific aims which concur to the possible clinical applications. Proposals will have to cover at least one of the specific areas listed under each aim below. Projects should be built from a solid and established hypothesis and should be relevant with regards to the possible improvements in clinical practices.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 04/12/2015
Deadline Pre-Proposal 05/02/2016 Submitted proposal: 34
Deadline Full-Proposal 26/05/2016 Submitted proposal: 14
Evaluation End Date 10/10/2016 Successful proposal: 7 Proposals funded: 7
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
Participating networks n/a

Organisations Participating

Country Organisation
Estonian Research Council duplicate to 998483760
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
France ARC French foundation for Cancer Research (ARC-France)
France National Cancer Institute (INCa)
Israel Ministry of Health (CSO-MOH)
Italy Alliance Against Cancer (ACC)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Poland National Centre for Research and Development (NCBiR)
Portugal Foundation for Science and Technology (FCT)
Slovakia Slovak Academy of Science (SAS/SAV)
Spain Foundation for Asturias Promotion of Applied Scientific Research and Technology (FICYT)
Spain Institute of Health Carlos III (ISCIII)
Taiwan MINISTRY OF SCIENCE AND TECHNOLOGY (MoST Taiwan)

Funded Projects

Acronym Title Start End No. partners
DIgesT Impact of Dietary Intervention on tumor immunity 01/12/2017 30/11/2020 6
EPICA Dual EPigenetic targeting and Immunotherapy to fight against... 01/03/2017 3
HEPAMUT Mutated neo-antigens in hepatocellular carcinoma 20/02/2017 19/02/2020 7
IMMUNOGLIO Deciphering immune response against glioblastoma to find new... 01/07/2017 30/06/2020 5
IMMUSPHINX Targeting sphingolipid metabolism to improve anti-melanoma i... 01/04/2017 31/03/2020 5
Microther Improving immunotherapy of solid tumors by targeting the imm... 01/12/2017 30/11/2020 5
RE-VOLU-TION pREdiction of niVOLUmab acTION in metastatic renal cancer pa... 13/03/2017 12/03/2020 4